Video

Dr. Baker on Approaching Palliative Care for Children With Cancer

Justin N. Baker, MD, chief, Division of Quality of Life and Palliative Care, attending physician, Quality of Life Service, St. Jude Children’s Research Hospital, discusses approaching palliative care for children with cancer.

Justin N. Baker, MD, chief, Division of Quality of Life and Palliative Care, attending physician, Quality of Life Service, St. Jude Children’s Research Hospital, discusses approaching palliative care for children with cancer.

Palliative care for children with cancer is inherently multidisciplinary, says Baker. A holistic approach must be taken with palliative or end-of-life care, which requires an entire team. This team will address issues related to suffering. Baker says that suffering is the antithesis of palliative care, just as the enemy of oncology is cancer. A child with cancer not only goes through physical symptoms, but psychosocial distress, spiritual and existential distress, and psychological distress.

A team approach looks all at angles of end-of-life care, which includes being there for the family of the child. Addressing the needs of the child, as well as the family who must re-enter the community, are ways that a team-based palliative care approach should operate, Baker says. This is a very complex part of cancer care, and cannot be done by 1 individual, making a team-based multidisciplinary approach imperative.

Related Videos
Alan Tan, MD, genitourinary oncology and melanoma specialist, Vanderbilt-Ingram Cancer Center; associate professor, medicine, Division of Hematology Oncology, Vanderbilt University Medical Center
Zosia Piotrowska, MD, MHS, instructor, Harvard Medical School; medical oncologist, Massachusetts General Hospital
Bartosz Chmielowski, MD
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD